People who recover from mild COVID-19 have bone-marrow cells that can churn out antibodies for decades, although viral variants could dampen some of the protection they offer.
Even Mild COVID-19 Cases Can Deliver Antibody Protection For Life, Study Finds
Even a mild case of COVID-19 can create antibodies that could give you lifetime protection from the virus, according to a new study. “Months after recovering from mild cases of COVID-19, people still …
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans | Nature
Abstract Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of protective antibodies1–7. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent individuals have a significantly lower risk of reinfection8–10. Nonetheless, …
SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition
The SARS-CoV-2 pandemic calls for the rapid development of diagnostic, preventive, and therapeutic approaches. CD4+ and CD8+ T cell-mediated immunity is central for control of and protection from viral infections[1-3]. A prerequisite to characterize T-cell …
We now have the best evidence yet that everyone develops long-term coronavirus immunity after infection — and it’s not just about antibodies
Source: We now have the best evidence yet that everyone develops long-term coronavirus immunity after infection — and it’s not just about antibodies
‘A huge boost’: Coronavirus patients feared to have been reinfected had returned false positives, says South Korea
Source: ‘A huge boost’: Coronavirus patients feared to have been reinfected had returned false positives, says South Korea | The Independent
